Sarah Elsabagh

650 total citations
16 papers, 505 citations indexed

About

Sarah Elsabagh is a scholar working on Psychiatry and Mental health, Cognitive Neuroscience and Complementary and alternative medicine. According to data from OpenAlex, Sarah Elsabagh has authored 16 papers receiving a total of 505 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Psychiatry and Mental health, 4 papers in Cognitive Neuroscience and 4 papers in Complementary and alternative medicine. Recurrent topics in Sarah Elsabagh's work include Neurological Disease Mechanisms and Treatments (4 papers), Ginkgo biloba and Cashew Applications (4 papers) and Dementia and Cognitive Impairment Research (3 papers). Sarah Elsabagh is often cited by papers focused on Neurological Disease Mechanisms and Treatments (4 papers), Ginkgo biloba and Cashew Applications (4 papers) and Dementia and Cognitive Impairment Research (3 papers). Sarah Elsabagh collaborates with scholars based in United Kingdom, Canada and United States. Sarah Elsabagh's co-authors include David E. Hartley, Sandra E. File, Helen Wiseman, Delia C. Randall, John M. Shneerson, Elizabeth M. Williamson, Veena Kumari, Anantha P. Anilkumar, Preethi Premkumar and Stacy A. Voils and has published in prestigious journals such as Psychopharmacology, Behavioural Brain Research and Schizophrenia Research.

In The Last Decade

Sarah Elsabagh

15 papers receiving 474 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Sarah Elsabagh United Kingdom 9 149 112 101 96 81 16 505
Mark Rodrigues Australia 11 65 0.4× 24 0.2× 78 0.8× 23 0.2× 167 2.1× 14 583
Aida Cuenca‐Royo Spain 14 120 0.8× 34 0.3× 30 0.3× 12 0.1× 81 1.0× 29 671
W. David Crews United States 14 145 1.0× 24 0.2× 20 0.2× 183 1.9× 123 1.5× 29 645
Franziska Pahlisch Germany 8 183 1.2× 40 0.4× 102 1.0× 13 0.1× 161 2.0× 10 906
Alexander Nies United States 14 53 0.4× 55 0.5× 45 0.4× 14 0.1× 228 2.8× 23 739
Çiğdem Aydemir Türkiye 10 57 0.4× 100 0.9× 17 0.2× 14 0.1× 112 1.4× 25 573
R Gomez United States 2 47 0.3× 10 0.1× 69 0.7× 19 0.2× 56 0.7× 8 622
Amaya Austrich-Olivares Spain 8 80 0.5× 21 0.2× 44 0.4× 10 0.1× 73 0.9× 10 601
Han-Yong Jung South Korea 10 39 0.3× 16 0.1× 34 0.3× 15 0.2× 150 1.9× 12 787
Rachel Barron United Kingdom 4 73 0.5× 16 0.1× 66 0.7× 17 0.2× 138 1.7× 6 554

Countries citing papers authored by Sarah Elsabagh

Since Specialization
Citations

This map shows the geographic impact of Sarah Elsabagh's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sarah Elsabagh with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sarah Elsabagh more than expected).

Fields of papers citing papers by Sarah Elsabagh

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sarah Elsabagh. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sarah Elsabagh. The network helps show where Sarah Elsabagh may publish in the future.

Co-authorship network of co-authors of Sarah Elsabagh

This figure shows the co-authorship network connecting the top 25 collaborators of Sarah Elsabagh. A scholar is included among the top collaborators of Sarah Elsabagh based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sarah Elsabagh. Sarah Elsabagh is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
Elsabagh, Sarah, et al.. (2022). Risk Factors for Delirium and Association of Antipsychotic Use with Delirium Progression in Critically Ill Trauma Patients. The American Surgeon. 89(5). 1610–1615. 3 indexed citations
2.
Elsabagh, Sarah, et al.. (2016). Global Health Learning - Are Students Demonstrating Insights Through Short Essays?. MedEdPublish. 5. 70–70. 3 indexed citations
3.
Pearce, Simon H. S., et al.. (2011). Hindfoot Plantarflexion: A Radiographic Aid to the Diagnosis of Achilles Tendon Rupture. The Journal of Foot & Ankle Surgery. 51(2). 176–178. 2 indexed citations
4.
Elsabagh, Sarah, et al.. (2010). Public awareness and prevention of malaria in Vanuatu. Public Health. 124(5). 295–297. 1 indexed citations
5.
Elsabagh, Sarah, Preethi Premkumar, Anantha P. Anilkumar, & Veena Kumari. (2009). A longer duration of schizophrenic illness has sex-specific associations within the working memory neural network in schizophrenia. Behavioural Brain Research. 201(1). 41–47. 18 indexed citations
6.
Elsabagh, Sarah, Preethi Premkumar, Anantha P. Anilkumar, & Veena Kumari. (2008). 205 – Duration of illness, sex and working memory in schizophrenia: An fMRI investigation. Schizophrenia Research. 98. 117–118. 1 indexed citations
7.
Elsabagh, Sarah, David E. Hartley, & Sandra E. File. (2006). Cognitive function in late versus early postmenopausal stage. Maturitas. 56(1). 84–93. 41 indexed citations
8.
Randall, Delia C., et al.. (2005). Does Modafinil Enhance Cognitive Performance in Young Volunteers Who Are Not Sleep-Deprived?. Journal of Clinical Psychopharmacology. 25(2). 175–179. 79 indexed citations
9.
Elsabagh, Sarah, et al.. (2005). Differential cognitive effects of Ginkgo biloba after acute and chronic treatment in healthy young volunteers. Psychopharmacology. 179(2). 437–446. 41 indexed citations
10.
File, Sandra E., et al.. (2005). Cognitive improvement after 6 weeks of soy supplements in postmenopausal women is limited to frontal lobe function. Menopause The Journal of The North American Menopause Society. 12(2). 193–201. 78 indexed citations
11.
Elsabagh, Sarah, David E. Hartley, & Sandra E. File. (2005). Limited cognitive benefits in Stage +2 postmenopausal women after 6 weeks of treatment with Ginkgo biloba. Journal of Psychopharmacology. 19(2). 173–181. 35 indexed citations
12.
Randall, Delia C., Sarah Elsabagh, David E. Hartley, & Sandra E. File. (2004). Does drinking have effects on mood and cognition in male and female students?. Pharmacology Biochemistry and Behavior. 78(3). 629–638. 8 indexed citations
13.
Elsabagh, Sarah, David E. Hartley, Delia C. Randall, Pallab Seth, & Sandra E. File. (2004). Mood changes after cognitive testing in late middle-age: impacts of sex and habitual alcohol consumption. Pharmacology Biochemistry and Behavior. 78(3). 621–628. 1 indexed citations
14.
Hartley, David E., Sarah Elsabagh, & Sandra E. File. (2004). Gincosan (A Combination of Ginkgo biloba and Panax ginseng ): The Effects on Mood and Cognition of 6 and 12 Weeks' Treatment in Post-menopausal Women. Nutritional Neuroscience. 7(5-6). 325–333. 35 indexed citations
15.
Hartley, David E., Sarah Elsabagh, & Sandra E. File. (2004). Binge drinking and sex: effects on mood and cognitive function in healthy young volunteers. Pharmacology Biochemistry and Behavior. 78(3). 611–619. 121 indexed citations
16.
Hartley, David E., et al.. (2003). Effects on cognition and mood in postmenopausal women of 1-week treatment with Ginkgo biloba. Pharmacology Biochemistry and Behavior. 75(3). 711–720. 38 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026